Immune-mediated - Immune thrombocytopenia (ITP)
- Drug-induced thrombocytopenia
- Systemic autoimmune disorders and immune dysregulation syndromes (secondary ITP)
- Systemic lupus erythematosus
- Autoimmune lymphoproliferative syndrome
- Antiphospholipid antibody syndrome
- Common variable immunodeficiency
- DiGeorge (22q11.2 deletion) syndrome
- Microangiopathic disorders
- Hemolytic-uremic syndrome
- Thrombotic thrombocytopenic purpura
- Disseminated intravascular coagulation
- Major surgery or trauma
- Kasabach-Merritt syndrome
- Extracorporeal therapies (eg, cardiopulmonary bypass)
- Hypersplenism
- Type 2B or platelet-type von Willebrand disease
| Infection - Epstein-Barr virus, cytomegalovirus, bacterial sepsis, parvovirus, varicella, rickettsia, dengue virus
- Aplastic anemia
- Myelodysplastic syndromes
- Medications (eg, chemotherapy)
- Radiation
- Leukemias
- Lymphomas
- Metastatic cancers
- Infectious granulomas
- Storage diseases
- Wiskott-Aldrich syndrome/X-linked thrombocytopenia
- Inherited bone marrow failure syndromes
- Fanconi anemia
- Dyskeratosis congenita
- Shwachman-Diamond syndrome
- Congenital amegakaryocytic thrombocytopenia
- Thrombocytopenia with absent radii syndrome
- Amegakaryocytic thrombocytopenia with radioulnar synostosis
- Familial platelet disorder with predisposition to hematologic malignancy
- Bernard-Soulier syndrome
- MYH9-related disorders
- Paris-Trousseau syndrome
- X-linked thrombocytopenia with dyserythropoiesis
|